16.43
Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten
Amylyx Investors To Get $6.5M In ALS Drug Settlement - Law360
Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia - Business Wire
Sarepta, Amylyx and Neumora look ahead to key catalysts as Q1 earnings roll in - BioSpace
MSN Money - MSN
H.C. Wainwright raises Amylyx stock price target to $34 on trial confidence - Investing.com
AMLX Stock Price, Quote & Chart | AMYLYX PHARMACEUTICALS INC (NASDAQ:AMLX) - ChartMill
Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - BioSpace
Amylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch - TipRanks
Press Release: Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - Moomoo
Amylyx sets May 7 earnings report, 8 a.m. ET webcast - Stock Titan
Amylyx Pharmaceuticals (AMLX) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Bank of America Securities Reaffirms Their Buy Rating on Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail
Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $21 From $19, Maintains Outperform Rating - marketscreener.com
BofA raises Amylyx Pharmaceuticals stock price target on model updates By Investing.com - Investing.com Nigeria
BofA raises Amylyx Pharmaceuticals stock price target on model updates - Investing.com
Mizuho raises Amylyx stock price target on lower expense outlook By Investing.com - Investing.com India
Mizuho Forecasts Strong Price Appreciation for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Mizuho raises Amylyx stock price target on lower expense outlook - Investing.com
Amylyx Pharmaceuticals Q3 2025 Earnings Preview - MSN
Amylyx Pharmaceuticals, Inc. ($AMLX) Co-CEO and Director 2025 Pay Revealed - Quiver Quantitative
[ARS] Amylyx Pharmaceuticals, Inc. SEC Filing - Stock Titan
Executive pay, avexitide milestones and 2026 vote at Amylyx (NASDAQ: AMLX) - Stock Titan
AMLX (Amylyx Pharmaceuticals Inc.) reports narrower Q4 2025 loss than estimates, shares climb 3.55 percent on positive investor sentiment.Revenue Per Share - Cổng thông tin điện tử tỉnh Lào Cai
AMLX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Amylyx (AMLX) Stock Stop Limit Order (-3.24%) 2026-04-20Pro Level Trade Signals - Xã Thanh Hà
Stock Traders Purchase High Volume of Call Options on Amylyx Pharmaceuticals (NASDAQ:AMLX) - MarketBeat
Amylyx Pharmaceuticals stock hits 52-week high at 17.5 USD By Investing.com - Investing.com Australia
Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL), ANI Pharmaceuticals (ANIP) and Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail
Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 12-Month HighShould You Buy? - MarketBeat
Amylyx Pharmaceuticals stock hits 52-week high at 17.5 USD - Investing.com
Guggenheim Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch - Yahoo Finance
Bull Run: What is Amylyx Pharmaceuticals Incs book value per share2026 Dividend Review & Daily Profit Maximizing Tips - baoquankhu1.vn
Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Singapore
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Layoff Watch: Is Amylyx Pharmaceuticals Inc stock a smart retirement pick2026 Patterns & AI Powered Trade Plan Recommendations - baoquankhu1.vn
AMLX SEC FilingsAmylyx Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - BioSpace
Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential - TipRanks
A Look At Amylyx Pharmaceuticals (AMLX) Valuation As Avexitide Hits A Key Phase 3 LUCIDITY Milestone - Sahm
Amylyx Pharmaceuticals Inc (AMLX) Shares Up 6.66% on Apr 6 - GuruFocus
Amylyx Pharmaceuticals Shares Rise 6.9% on Positive News - National Today
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):